iData’s global catheter securement devices market MedCore includes a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

iData’s global peripherally inserted central catheter market MedCore covers both the non-power-injectable peripherally inserted central catheter market and the power-injectable peripherally inserted central catheter market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

The transcatheter embolization market is segmented into four types of devices: particle embolics, coil embolics, liquid embolics and vascular plugs. Detachable balloons are also used for embolization procedures, but are not covered in this report because they are rarely used.

Thrombosis is defined as the formation of a blood clot inside a blood vessel, which obstructs the flow of blood. Thrombus can become life threatening if it dislodges from the vessel wall and enters the lungs or other vital organ. A fragment of thrombus traveling through the vascular system is called an embolus.

The global peripheral vascular stents market size is expected to reach over $3,828 million by 2026, with the drug-eluting stent market segment showing the highest growth rate.

The majority of the global peripheral vascular stents share was controlled by W.L. Gore, Boston Scientific and Medtronic.

The global peripheral chronic total occlusion (CTO) device market is expected to increase over the forecast period to reach $258.2 million by 2026. This global market research on chronic total occlusion (CTO) devices spans over 70 countries and includes re-canalization and re-entry devices, considered jointly in the analysis.

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation, if left untreated.

Lumen stenosis can occur due to the accumulation of thrombosis or plaque particles in a similar manner to peripheral arterial disease. The accumulation of these plaque particles has also been shown to cause calcification. Lumen stenosis is a considerable problem for both arteriovenous (AV) access surgical grafts and native fistulae because they have poor vessel patency. Due to their tendency to acquire blockages, AV access surgical grafts will require revascularization twice a year, and native fistulae will need to be cleared at least once a year.

Intravascular ultrasound (IVUS) can be used as an alternative or adjunctive imaging technique in peripheral procedures. IVUS provides the physician a cross-sectional image of the vessel. An IVUS system consists of two components: the disposable IVUS catheter and the IVUS console.

Introducer sheaths are used for facilitating the insertion of devices into vasculature. These devices include guidewires and catheters that are used during peripheral interventional procedures. In addition, these devices also simplify the application of patches and closure devices to allow hemostasis to occur.

Inferior vena cava filters (IVCFs) prevent pulmonary embolism by intercepting a thrombus before it can enter the circulatory system of the lungs. In general, IVCFs are composed of a nest or lattice of wire collapsed around a catheter that is used to guide the filter. The filter is then expanded or deployed at the desired location, usually just below the junction of the inferior vena cava and the lowest renal vein.

Drug-coated balloons have emerged as a promising technology for treating peripheral arterial disease (PAD). These devices are similar to traditional balloon dilation catheters, but feature a drug coating designed to combat restenosis. As of January 2018, DCBs are approved in the United States for use in treating lesions of the superficial femoral artery (SFA) and in AV access procedures. However, several companies are in the process of obtaining approval for BTK use of DCBs.

Carotid endarterectomy is a surgical procedure performed to clean plaque off the carotid artery walls, thus reducing the risk of stroke. A vascular surgeon may recommend a carotid endarterectomy if a patient exhibits a moderate (50-70%) or severe (80% or greater) blockage of a carotid artery.

Carotid stenting can be accompanied with plaque dislodgment and plaque emboli. Thus, the initial popularity of carotid stents were tainted as these artifacts caused an unacceptably high incidence rate of strokes. Since then, the industry has responded by manufacturing embolic protection devices (EPDs). These devices are used to capture dislodged vascular debris.
There are many different EPD platforms available for use in the peripheral vascular market, including filters, arterial occlusion balloons and devices that redirect blood flow.

Introducer sheaths are used for facilitating the insertion of devices into vasculature. These devices include guidewires and catheters that are used during peripheral interventional procedures. In addition, these devices also simplify the application of patches and closure devices to allow hemostasis to occur.

Accurate product and industry research is a time consuming and costly affair, but a necessary part of any successful market player. Our MedFolio™ line of products can ease research burdens by compiling the latest product information across an entire market segment. We have aggregated hundreds of products by category and company, as well as comprehensive lists of press releases, regulatory announcements and future product developments. MedFolio is ideal for companies with small or limited research teams as well as those who need to supplement their research departments with new data. A MedFolio includes the following products (*Not all products are available in every MedFolio, for more information, consult the MedFolio product page of a specific report):
Executive Summary
Product Introductions
Product Portfolio (Current Products on Market)
Product Pipelines (Future Products)
Clinical Trials